CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-27 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-02-13 | Booth Bruce Director | Purchase | +545,454 | $5.50 | $3.0M | 1,351,090 |
| 2018-01-03 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +10,191 | 10,191 | ||
| 2017-06-28 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-03-24 | Booth Bruce Director | Grant or award · Stock Option (right to buy) | +6,844 | 6,844 |
Page 1 of 1 · 5 trades